Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 9/2021

01-09-2021 | Obesity | Brief Communication

Initial Experience with Alternate-Day Liraglutide for Weight Regain Following Bariatric Surgery

Authors: Miguel A. Rubio, Ana M Ramos-Leví

Published in: Obesity Surgery | Issue 9/2021

Login to get access

Graphical abstract

Appendix
Available only for authorised users
Literature
1.
Istfan NW, Lipartia M, Anderson WA, et al. Approach to the patient: management of the post-bariatric surgery patient with weight regain. J Clin Endocrinol Metab. 2021 Jan 1;106(1):251–63.CrossRef
2.
Miras AD, Pérez-Pevida B, Aldhwayan M, et al. Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2019;7(7):549–59.CrossRef
3.
Rye P, Modi R, Cawsey S, et al. Efficacy of high-dose liraglutide as an adjunct for weight loss in patients with prior bariatric surgery. Obes Surg. 2018 Nov;28(11):3553–8.CrossRef
4.
Wharton S, Kuk JL, Luszczynski M, et al. Liraglutide 3.0 mg for the management of insufficient weight loss or excessive weight regain post-bariatric surgery. Clin Obes. 2019;9(4):e12323.CrossRef
5.
Thakur U, Bhansali A, Gupta R, et al. Liraglutide augments weight loss after laparoscopic sleeve gastrectomy: a randomised, double-blind, placebo-control study. Obes Surg. 2021 Jan;31(1):84–92.CrossRef
6.
7.
Wharton S, Liu A, Pakseresht A, et al. Real-world clinical effectiveness of liraglutide 3.0 mg for weight management in Canada. Obesity (Silver Spring). 2019 Jun;27(6):917–24.CrossRef
8.
Metadata
Title
Initial Experience with Alternate-Day Liraglutide for Weight Regain Following Bariatric Surgery
Authors
Miguel A. Rubio
Ana M Ramos-Leví
Publication date
01-09-2021
Publisher
Springer US
Published in
Obesity Surgery / Issue 9/2021
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-021-05535-2

Other articles of this Issue 9/2021

Obesity Surgery 9/2021 Go to the issue

Original Contributions

The Changes in Body Composition in Obese Patients with Polycystic Ovary Syndrome after Laparoscopic Sleeve Gastrectomy:a 12-Month Follow-up

Original Contributions

Weight Regain Outcomes After Bariatric Surgery in the Long-term Follow-up: Role of Preoperative Factors

Original Contributions

BMI Course Over 10 Years After Bariatric Surgery and Biopsychosocial Complexity Assessed with the INTERMED: a Retrospective Study

Original Contributions

Indications and Outcomes of Conversion of Sleeve Gastrectomy to Roux-en-Y Gastric Bypass: a Systematic Review and a Meta-analysis

Letter to the Editor

Ruptured Splenic Artery Pseudoaneurysm 3 Years After Laparoscopic Sleeve Gastrectomy

Original Contributions

Introducing a Bariatric Surgery Program at a Large Urban Safety Net Medical Center Serving a Primarily Hispanic Patient Population